By partnering with ABio-X and our suite of experienced operators, our member companies can make significant R&D progress while being capital efficient. With certain R&D and G&A functions covered, we allow our executives to focus on what really matters: progressing their pipelines to help patients in need. By utilizing our unique model, we assist our member companies to grow at their own pace, supporting them when needed, every step of the way.
Adcentrx Therapeutics: A San Diego-based clinical-stage biotechnology company focused on accelerating breakthroughs in developing protein conjugate therapeutics for cancer and other life-threatening diseases.
Ensem Therapeutics: A Boston-based pioneering drug discovery and development company that leverages its unique Kinetic Ensemble® platform to develop innovative small molecule precision medicines for oncology.